CVS Returns Zepbound to Drug Plans After Lilly Slashes Price

Health

Cvs Returns Zepbound To Drug Plans After Lilly Slashes Price

By Bloomberg.com

More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans. The reversal comes after Lilly agree ...Read more